TRXC - Medical Robotics Stocks Continued
Robotic-Assisted Surgery on the Rise
In earlier articles, we have discussed how the medical robotics sector has strong growth prospects. Robotic surgery currently accounts for less than 10% of total surgeries, according to TransEnterix (NYSEMKT:TRXC), with "continued expansion into additional procedures and new global markets" driving growth. WinterGreen Research forecasts that the market for abdominal robotic surgery will reach $15.8 billion by 2023.
Market research firm MarketsAndMarkets ("MNM") expects the overall medical robots market "to register a CAGR of 21.0% during the forecast period [of 2018-2023] to reach $16.74 billion by 2023 from